A Study of the Safety and Effectiveness of a R256918 in Patients With Type 2 Diabetes

NCT00672386 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

352

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type 2
Diabetes Mellitus
Endocrine System Diseases
Nutritional and Metabolic Diseases

Interventions

DRUG: JNJ16269110
DRUG: JNJ16269110
DRUG: JNJ16269110
DRUG: Placebo
DRUG: Metformin
OTHER: Dietary Counseling

Sponsor

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.